shop by category
Our Products
Dilutions
Constance Therapeutics’ cartridges
pair with Jupiter Research’s battery-
charged “Liquid9” vaporizer pen.
Topicals
Constance Therapeutics also offers two unique
39k Protocol ratios that may stimulate the
body’s endocannabinoid response: 1:1 or 1:4
(CBD:THC). By attenuating throughout the
course of a protocol, patients orally ingest
39,000 mg contained in 65 grams of cannabis
-rich extract compounds over an approximate
90-day period.
Constance Therapeutics also offers two unique 39k Protocol ratios that may stimulate the body’s endocannabinoid response: 1:1 or 1:4 (CBD:THC). By attenuating throughout the course of a protocol, patients orally ingest 39,000 mg contained in 65 grams of cannabis -rich extract compounds over an approximate 90-day period.
